P H Capital Board to Consider Standalone Q2 FY27 Results Nov 14

P. H. Capital Ltd will hold a board meeting on November 14, 2026, to consider unaudited standalone financial results for the quarter and half year ended September 30, 2026. The meeting is a required disclosure event for the micro-cap non-banking financial company and follows the company’s approved 10:1 bonus share allotment.

What will P H Capital's board consider on November 14?

P H Capital's board is scheduled to consider and approve the company’s unaudited standalone financial results for the second quarter and first half of FY27. The meeting intimation was issued under Regulation 29(1) of the Securities and Exchange Board of India’s Listing Obligations and Disclosure Requirements Regulations, 2015.

The disclosure identifies November 14, 2026, a Saturday, as the meeting date. It concerns the period ended September 30, 2026, which covers the July-September quarter and the six months from April through September. Until the board considers the financial statements, the meeting notice itself does not establish a final set of earnings figures.

The supplied announcement record also states that the trading window was closed in connection with the proposed results. Such restrictions are routinely applied by listed companies while unpublished price-sensitive financial information is being considered, limiting trading by designated persons during the restricted period.

Which reporting period will the standalone results cover?

The proposed financial statements cover Q2 FY27 and H1 FY27, both ending on September 30, 2026. Quarterly results will show the company’s standalone performance for the three months ended on that date, while the half-yearly statement will aggregate the first two quarters of the financial year.

The company has been identified as a non-banking financial company, although its supplied disclosures also refer to share and securities trading activities. Standalone reporting relates to P H Capital’s own financial position and operations rather than the combined results of any subsidiaries or associates.

The source material contains multiple, inconsistent figures described as Q2 FY27 results, including references to profits, losses, income and one-off gains. It also includes statements saying results were approved on November 10 and published on November 11, alongside the November 14 board-meeting intimation. Because these dates and figures are not internally consistent, they should not be treated as a verified financial result until P H Capital releases the board-approved filing and limited review report.

What information has P H Capital disclosed about the meeting?

P H Capital has disclosed the meeting under the SEBI listing framework, with the agenda focused on unaudited standalone results. This is the central confirmed event in the material provided, and investors should distinguish it from performance numbers appearing in unrelated or conflicting extracts.

The company is listed under BSE scrip code 500143. The supplied market snapshot places its share price at ₹119.15 and classifies its market capitalisation as micro-cap, but it does not provide a timestamp for that price. Therefore, the figure is useful only as a disclosed reference point and not as evidence of the stock’s reaction to the board-meeting notice.

What other corporate action has P H Capital approved?

P H Capital previously approved an allotment of 3,00,01,000 bonus shares in the ratio of 10:1, according to the supplied October 8, 2026 disclosure record. A 10:1 bonus issue means shareholders receive 10 additional shares for every one share held on the applicable record date, subject to the terms of the corporate action.

The same October disclosure record says the company appointed Shrusti Barlota as Company Secretary and Compliance Officer with effect from October 8, 2026. It also referred to plans for three subsidiaries. The provided information does not specify whether those subsidiary plans have since been implemented, so their financial or operational effects cannot be assessed from this material.

For shareholders, the bonus issue changes the number of shares held but does not by itself create additional underlying value. The market price is typically adjusted for the increased share count once the bonus shares become effective. Investors should use the company’s exchange filings to confirm record-date, credit and listing details.

Why does the November 14 meeting matter to investors?

The November 14 meeting matters because it is the stated point at which P H Capital’s standalone September-quarter and half-year financial statements are expected to receive board consideration. The eventual results filing should provide the relevant income statement, balance-sheet and cash-flow details, along with per-share information and the statutory auditor’s limited review report.

For a micro-cap company, clarity and consistency of exchange disclosures are particularly important. The conflicting earnings references within the supplied material make the formal BSE filing more relevant than secondary summaries. Investors assessing the company should compare the final results with the corresponding prior-year period and review whether any income or profit was recurring or arose from exceptional transactions.

The available information does not provide a verified explanation of business performance for the September 2026 quarter. It also does not provide analyst estimates, a management outlook, or a confirmed share-price movement following the notice. As a result, conclusions about earnings momentum or valuation would be premature before the complete financial statements are available.

Conclusion

P H Capital has notified the market that its board will consider unaudited standalone Q2 FY27 and H1 FY27 results on November 14, 2026, for the period ended September 30. The company has also disclosed a 10:1 bonus allotment involving 3,00,01,000 shares, while the supplied financial-result extracts contain inconsistencies that prevent reliable use of those figures.

The next item to watch is P H Capital’s board-approved results announcement, including the detailed financial statements and limited review report. Investors should also monitor exchange disclosures for the operational status of the proposed subsidiaries and any remaining implementation details of the bonus issue.